Skip to main content
HR 3396 116th Congress House

Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019

Official title: To expand the research activities of the National Institutes of Health with respect to functional gastrointestinal and motility disorders, and for other purposes.

Introduced: March 9, 2020 See on congress.gov
Health Digestive and metabolic diseasesGovernment information and archivesHealth information and medical recordsHealth programs administration and funding
More subjectsShow fewer subjects
Medical researchMedical tests and diagnostic methodsResearch administration and funding
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 21, 2019
Referred to the Subcommittee on Health.
Jun 20, 2019
Referred to the House Committee on Energy and Commerce.
Jun 20, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 21, 2019

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019

This bill allows the National Institutes of Health to expand, intensify, and coordinate its activities with respect to functional gastrointestinal and motility disorders (FGIMDs), including by

  • expanding basic and clinical research into FGIMDs by implementing the research recommendations of the National Commission on Digestive Diseases,
  • providing support for the establishment of centers of excellence on FGIMDs,
  • supporting innovative approaches to educating health care providers and patients regarding strategies that improve patient-provider relationships and care,
  • directing the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to provide the necessary funding for the continued expansion and advancement of the FGIMDs research portfolio, and
  • directing NIDDK and the Eunice Kennedy Shriver National Institute of Child Health and Human Development to expand research into FGIMDs that impact children.

The Department of Health and Human Services may engage in public awareness and education activities to increase understanding and recognition of FGIMDs.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3396: Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-3396/
MLA
"H.R. 3396: Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-3396/.
Bluebook (legal)
H.R. 3396, 116th Cong. (2026), https://openamerica.io/bill/116-HR-3396/.
Markdown link
[H.R. 3396: Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019](https://openamerica.io/bill/116-HR-3396/)
Report a problem